Drugs Made in America Acquisition Corp. (NASDAQ:DMAAU – Get Free Report)’s share price shot up 0.4% on Tuesday . The stock traded as high as $10.17 and last traded at $10.17. 451 shares were traded during mid-day trading, a decline of 100% from the average session volume of 104,418 shares. The stock had previously closed at $10.13.
Drugs Made in America Acquisition Stock Performance
The business’s 50 day simple moving average is $10.09.
About Drugs Made in America Acquisition
Drugs Made In America Acquisition Corp. is a blank check company newly incorporated in the Cayman Islands as an exempted company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses.
See Also
- Five stocks we like better than Drugs Made in America Acquisition
- What is the Nikkei 225 index?
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- What Are Dividend Challengers?
- Top 3 Beverage Stocks Pouring Out Profits
- Investing in Construction Stocks
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Drugs Made in America Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Drugs Made in America Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
